Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Tichy · SciRah

Researcher profile · Semantic Scholar

D. Tichy

Share profile

D. Tichy — researcher profile on SciRah

h-index: 20
Works: 37
Citations: 1,251

Most-cited papers

Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla
Matthias Roethke, T. Kuru, S. Schultze, D. Tichy +4 more
2014European Radiology151 citations
Semantic Scholar
Prediction of malignancy by a radiomic signature from contrast agent‐free diffusion MRI in suspicious breast lesions found on screening mammography.
S. Bickelhaupt, D. Paech, P. Kickingereder, F. Steudle +10 more
2017Journal of Magnetic Resonance Imaging120 citations Open access
Semantic Scholar
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma
L. Leypoldt, D. Tichy, B. Besemer, M. Hänel +23 more
2023Journal of Clinical Oncology106 citations Open access
Semantic Scholar
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial.
H. Goldschmidt, E. Mai, U. Bertsch, R. Fenk +30 more
2022The Lancet Haematology102 citations
Semantic Scholar
Performance Evaluation of MHC Class-I Binding Prediction Tools Based on an Experimentally Validated MHC–Peptide Binding Data Set
M. Bonsack, S. Hoppe, Jan Winter, D. Tichy +5 more
2019Cancer immunology research78 citations Open access
Semantic Scholar
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial
E. Mai, U. Bertsch, Ema Požek, R. Fenk +33 more
2024Journal of Clinical Oncology73 citations Open access
Semantic Scholar
Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study--The IPI Trial.
G. Habl, M. Uhl, S. Katayama, K. Kessel +10 more
2016International Journal of Radiation Oncology, Biology, Physics61 citations
Semantic Scholar
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial
L. Leypoldt, B. Besemer, A. Asemissen, M. Hänel +18 more
2021Leukemia60 citations Open access
Semantic Scholar
Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial
H. Goldschmidt, E. Mai, J. Dürig, C. Scheid +27 more
2020Leukemia57 citations
Semantic Scholar
Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.
Sina Burth, P. Kickingereder, Oliver Eidel, D. Tichy +10 more
2016Neuro-Oncology46 citations Open access
Semantic Scholar
Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progression
J. M. Pickl, D. Tichy, V. Kuryshev, Y. Tolstov +11 more
2016OncoTarget43 citations Open access
Semantic Scholar
Complete bladder neck preservation promotes long-term post-prostatectomy continence without compromising midterm oncological outcome: analysis of a randomised controlled cohort
J. Nyarangi-Dix, D. Tichy, G. Hatiboglu, S. Pahernik +2 more
2018World journal of urology34 citations
Semantic Scholar
Targeting atypical protein kinase C iota reduces viability in glioblastoma stem‐like cells via a notch signaling mechanism
E. Phillips, Verena Lang, J. Bohlen, Frederic Bethke +6 more
2016International Journal of Cancer30 citations Open access
Semantic Scholar
First Results of the Risk-Adapted, MRD-Stratified GMALL Trial 08/2013 in 705 Adults with Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma (ALL/LBL)
N. Goekbuget, M. Stelljes, A. Viardot, K. Nachtkamp +22 more
2021Blood29 citations
Semantic Scholar
Restoration of miR-127-3p and miR-376a-3p counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells by targeting COA1, GLE1 and PDIA6.
J. Fellenberg, Heiner Sähr, P. Kunz, Zhe-Fu Zhao +3 more
2016Cancer Letters29 citations
Semantic Scholar
Addition of Isatuximab to Lenalidomide, Bortezomib and Dexamethasone As Induction Therapy for Newly-Diagnosed, Transplant-Eligible Multiple Myeloma Patients: The Phase III GMMG-HD7 Trial
H. Goldschmidt, E. Mai, E. Nievergall, R. Fenk +29 more
2021Blood28 citations Open access
Semantic Scholar
Long-term ovarian function in women treated with CHOP or CHOP plus etoposide for aggressive lymphoma.
J. Meissner, D. Tichy, V. Katzke, T. Kühn +9 more
2014Annals of Oncology28 citations Open access
Semantic Scholar
Predictive factors for immediate continence after radical prostatectomy
G. Hatiboglu, D. Teber, D. Tichy, S. Pahernik +3 more
2015World journal of urology23 citations
Semantic Scholar
Depth of response to isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: Interim analysis of the GMMG-CONCEPT trial.
K. Weisel, A. Asemissen, B. Besemer, M. Haenel +16 more
202022 citations
Semantic Scholar
Body fat composition as predictive factor for treatment response in patients with newly diagnosed multiple myeloma – subgroup analysis of the prospective GMMG MM5 trial
Jonathan P. GroΔ, Johanna Nattenmüller, Stefan Hemmer, D. Tichy +7 more
2017OncoTarget22 citations Open access
Semantic Scholar
Dose Reduced Chemotherapy in Sequence with Blinatumomab for Newly Diagnosed Older Patients with B-Precursor Adult Lymphoblastic Leukemia (ALL): Results of the Ongoing GMALL Bold Trial
N. Goekbuget, Andrea Stoltefuss, M. Topp, S. Schwartz +10 more
2021Blood18 citations Open access
Semantic Scholar
Parenthood in long‐term survivors after CHOP with or without etoposide treatment for aggressive lymphoma
J. Meissner, D. Tichy, S. Dietrich, T. Schmitt +6 more
2014British Journal of Haematology14 citations Open access
Semantic Scholar
Measured Multipoint Ultra-High b-Value Diffusion MRI in the Assessment of MRI-Detected Prostate Lesions
A. A. Tavakoli, T. Kuder, D. Tichy, J. Radtke +6 more
2020Investigative Radiology13 citations
Semantic Scholar
Isatuximab, Carfilzomib, Lenalidomide and Dexamethasone (I-KRd) in front-line treatment of high-risk Multiple Myeloma: Results of the Safety Run-In cohort in the phase II, multicenter GMMG-CONCEPT trial
K. Weisel, A. Asemissen, Aneta Schieferdecker, B. Besemer +7 more
2019Clinical Lymphoma, Myeloma & Leukemia11 citations
Semantic Scholar
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone (Isa-KRd) in Patients with High-Risk Newly Diagnosed Multiple Myeloma: Planned Interim Analysis of the GMMG-Concept Trial
K. Weisel, B. Besemer, M. Haenel, R. Lutz +20 more
2022Blood9 citations Open access
Semantic Scholar
Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial
Eva-Maria Klein, D. Tichy, H. Salwender, E. Mai +22 more
2021Cancers9 citations Open access
Semantic Scholar
Diffusion‐weighted MRI treatment monitoring of primary hypofractionated proton and carbon ion prostate cancer irradiation using raster scan technique
M. Wolf, Christopher Edler, D. Tichy, M. Röthke +3 more
2017Journal of Magnetic Resonance Imaging8 citations Open access
Semantic Scholar
Antibiotic Prophylaxis or Granulocyte-Colony Stimulating Factor Support in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
E. Klein, Sandra Sauer, Sabrina Klein, D. Tichy +8 more
2021Cancers6 citations Open access
Semantic Scholar
Bone Marrow Immune Signatures in Multiple Myeloma Are Linked to Tumor Heterogeneity and Treatment Outcome
Simon Steiger, R. Lutz, Nina Prokoph, S. Palit +31 more
2022Blood5 citations Open access
Semantic Scholar
Experimental design and data analysis of Ago‐RIP‐Seq experiments for the identification of microRNA targets
D. Tichy, J. M. Pickl, A. Benner, H. Sültmann
2018Briefings Bioinform.4 citations
Semantic Scholar
Erratum to: Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla
Matthias Roethke, T. Kuru, S. Schultze, D. Tichy +4 more
2014European Radiology4 citations Open access
Semantic Scholar
P930: ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE AS INDUCTION THERAPY FOR NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH HIGH-RISK CYTOGENETICS: A SUBGROUP ANALYSIS FROM THE GMMG-HD7 TRIAL
E. Mai, U. Bertsch, R. Fenk, D. Tichy +30 more
2022HemaSphere3 citations Open access
Semantic Scholar
Depth of Response to Isatuximab, Carfilzomib, Lenalidomide and Dexamethasone (Isa-KRd) in Front-Line Treatment of High-Risk Multiple Myeloma: Interim Analysis of the GMMG-CONCEPT Trial
L. Leypoldt, A. Asemissen, B. Besemer, M. Haenel +18 more
2021Social Science Research Network2 citations
Semantic Scholar
Prognostic Impact of the Hevylite Assay in Patients With IgG or IgA Multiple Myeloma Treated Within the GMMG‐MM5 Trial
T. Richardson, E. Mai, Ekaterina Menis, A. Benner +18 more
2025European Journal of Haematology1 citations Open access
Semantic Scholar
Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myeloma
L. Leypoldt, D. Tichy, B. Besemer, Mathias Hanel +23 more
2024Future Oncology0 citations Open access
Semantic Scholar
OA-43 Analysis of sustained MRD-negativity and progression-free survival of Isa-KRd in high-risk newly diagnosed multiple myeloma – additional data from planned interim analysis of the GMMG-CONCEPT trial
L. Leypoldt, D. Tichy, B. Besemer, M. Hänel +21 more
2023Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
Normalization of serum free light chains during therapy in the MM5 trial predicts prolonged progression free survival and overall survival
Eva-Maria Haas, H. Salwender, E. Mai, J. Durig +30 more
2019Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

B. Besemer×16
Invite
B. Besemer — researcher profile on SciRah
K. Weisel×16
Invite
K. Weisel — researcher profile on SciRah
H. Salwender×13
Invite
H. Salwender — researcher profile on SciRah
H. Goldschmidt×13
Invite
H. Goldschmidt — researcher profile on SciRah

×12

Invite

C. Mann — researcher profile on SciRah

Invite

M. Munder — researcher profile on SciRah

Invite

A. Jauch — researcher profile on SciRah

Invite

U. Bertsch — researcher profile on SciRah

Invite

E. Mai — researcher profile on SciRah

Invite

A. Benner — researcher profile on SciRah

Invite

M. Raab — researcher profile on SciRah

Invite

M. Zago — researcher profile on SciRah